Sponsor

Centro Universitario de Ciencias de la Salud, Mexico

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Centro Universitario de Ciencias de la Salud, Mexico appears in 15 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials15
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

15 shown
Thymol on Netrin-1 on Obese PatientsNCT05427721 · lead sponsor · 2022-04-01
UNKNOWN
Flaxseed Supplementation in Prediabetic Adults (LINAPRED)NCT05245825 · lead sponsor · 2021-11-20
UNKNOWN
Acute Effect of Empagliflozin vs Dapagliflozin Over Pulse Wave Velocity in Type Two DiabetesNCT05109949 · lead sponsor · 2020-03-30
UNKNOWN
Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes MellitusNCT04195243 · lead sponsor · 2019-12-02
UNKNOWN
Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-IINCT03905018 · lead sponsor · 2019-05-01
UNKNOWN
Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial HypertensionNCT03626259 · lead sponsor · 2018-08-06
UNKNOWN
Green Tea Extract on Soluble RAGE in Patients With Diabetic NephropathyNCT03622762 · lead sponsor · 2018-07-15
UNKNOWN
Effect of Green Tea Extract on Lipids in Patients With Type 2 DiabetesNCT04532385 · lead sponsor · 2018-06-12
COMPLETED
Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With HypertensionNCT03294070 · lead sponsor · 2017-09-01
UNKNOWN
Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes MellitusNCT02627898 · lead sponsor · 2016-01-01
COMPLETED
Acetylsalicylic Acid and Type 2 Diabetes MellitusNCT03341117 · lead sponsor · 2014-12-02
COMPLETED
Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV PatientsNCT02008214 · lead sponsor · 2013-12-01
UNKNOWN
Effects of Lipoic Acid on Oxidative, Inflammatory and Functional Markers in Asthmatic PatientsNCT01221350 · lead sponsor · 2010-11-01
COMPLETED
Effect of Oral Administration of a Herbarium Mixture (Guazuma Ulmifolia and Tecoma Stans) on Metabolic Profile in Type 2 Diabetic PatientsNCT03313856 · lead sponsor · 2010-01-10
COMPLETED
Effects of n-3 Intake on Lipid Profile, Biochemical and Inflammatory Markers in Subjects With ObesityNCT04901052 · collaborator · 2018-01-10
COMPLETED

Drugs studied in this sponsor's trials

9 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Centro Universitario de Ciencias de la Salud, Mexico as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo3
green tea extract2
aspirin1
dapagliflozin 10 MG Oral Tablet1
empagliflozin 25 MG1
losartan1
pentoxifylline1
tadalafil 20 MG1

Sponsor roles

lead sponsor14
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.